Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players

GBI Research, the leading business intelligence provider, has released its latest research, "Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players", which provides in-depth analysis of the key therapeutic indications of oncology, breast cancer, colorectal cancer, prostate cancer, lung cancer and Non-Hodgkin’s Lymphoma (NHL), with forecasts until 2018. It also looks at treatment usage patterns and includes insights into the oncology R&D pipeline.

The Indian oncology therapeutics market for breast cancer, lung cancer, colorectal cancer, prostate cancer and NHL was estimated to be worth $153.3m in 2011, having grown at a Compound Annual Growth Rate (CAGR) of 12.7% from 2004. It is expected to reach $238.8m in 2018 at a CAGR of 6.5% from 2011. The slower growth in the forecast period is mainly due to the reduction in the price of leading marketed products for breast cancer, colorectal cancer, lung cancer and NHL after all 348 drugs on the National List of Essential Medicines (NLEM) are brought under price control regulations.

View Complete Report with TOC:
http://www.reportsandintelligence.com/oncology-therapeutics-in-india-to-2018-introduction-of-based-pricing-to-fuel-price-wars-and-intense-competition-among-domestic-and-multinational-players-market

The limitations of the current market are unclear patent laws, restrictive pricing and reimbursement policies, ailing infrastructure, and insufficient government aid. Low patient affordability is also a major restraint, and one that reimbursement and insurance policies must address if the market is to develop in the future.

Table Of Contents

1 Table of Contents
2 Oncology Therapeutics Market in India - Introduction
3 Oncology Therapeutics Market in India - Market Overview
3.1 Population Dynamics
3.2 Cancer Registration Background in India
3.3 Most Common Cancers in India
3.4 Cancer Mortality Rate
3.5 Market Characterization and Forecasts
3.6 Annual Cost of Therapy
3.7 Treatment Usage Pattern
4 Oncology Therapeutics Market in India - Therapeutic Landscape
4.1 Breast Cancer
4.2 Colorectal Cancer
4.3 Prostate Cancer
4.4 Lung Cancer
4.4.1 Disease Overview
4.5 Non-Hodgkin’s Lymphoma
4.5.1 Disease Overview
5 Oncology Therapeutics Market in India - Pipeline Analysis
6 Oncology Therapeutics Market in India - Competitive Landscape
7 Oncology Therapeutics Market in India - Strategic Consolidations
8 Oncology Therapeutics Market in India - Appendix

Web Link: http://www.reportsandintelligence.com/